ArticleThe Journal of allergy and clinical immunology2015

β₂-Agonist therapy may contribute to the air pollution and IL-6-associated risk of developing severe asthma with dual-positive TH2/TH17 cells.

Sergio E Chiarella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.